![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Wuhan Calmland Pharmaceuticals Co., Ltd. Wuhan Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Paclitaxel, produced by a semi-synthetic process, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-004 - Rev 02
This Chemical Type CEP, issued on May 27, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1794 associated with this CEP further emphasizes